SynthesisScientific reports2016

Amrubicin for relapsed small-cell lung cancer: a systematic review and meta-analysis of 803 patients.

Nobuyuki Horita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.